Complex formation processes and metal ion catalyzed oxidation of model peptides related to the metal binding site of the human prion protein by Csire, Gizella et al.
Contents lists available at ScienceDirect
Journal of Inorganic Biochemistry
journal homepage: www.elsevier.com/locate/jinorgbio
Complex formation processes and metal ion catalyzed oxidation of model
peptides related to the metal binding site of the human prion protein
Gizella Csire, Ildikó Turi, Imre Sóvágó, Eszter Kárpáti, Csilla Kállay⁎
Department of Inorganic and Analytical Chemistry, University of Debrecen, H-4032 Debrecen, Hungary
A B S T R A C T
Interaction of copper(II) and nickel(II) ions with the Ac-PHAAAGTHSMKHM-NH2 tridecapeptide containing the His85, His96 and His111 binding sites of human
prion protein has been studied by various techniques. pH-potentiometry, UV–Vis and circular dichroism spectroscopy were applied to study the stoichiometry,
stability and structure of the copper(II) and nickel(II) complexes, while HPLC-MS and MS/MS were used for identifying the products of copper(II) catalyzed
oxidation. The copper binding ability of shorter fragments, namely the nonapeptide Ac-PHAAAGTHS-NH2 and pentapeptide Ac-PHAAA-NH2 have also been studied.
The tridecapeptide is able to bind three equivalent of copper(II) ion, since the histidine residues behave as independent metal binding sites. Nevertheless, the metal
binding ability of histidine residue mimicking the octarepeat domain (His85) is decreased, while the other parts of the peptide mimicking the histidines outside the
octarepeat domain bind the copper ions in comparable concentration. On the other hand, this peptide is able to coordinate only two equivalents of nickel ion on the
domains outside the octarepeat region. Furthermore the His96 binding site is more effective for the nickel ions. Both histidine and methionine residues are sensitive
for oxidation, the oxidation of these residues are proved, and in the case of the histidine residues follows the order His96>His85≫His111.
1. Introduction
The human cellular prion protein, denoted PrPC consists of 231
amino acids. PrPC can be divided into two distinct regions: a flexible N-
terminal region that is essentially unstructured and a C-terminal region
comprising three α-helical structures and two small anti-parallel β-
sheet structures [1,2]. Prion diseases, also known as transmissible
spongiform encephalopathies (TSE), are a family of fatal neurodegen-
erative disorders. They include scrapie in sheep and goats, bovine
spongiform encephalopathy in cattle, chronic wasting disease in deer,
elk and kuru, Creutzfeldt-Jakob disease, fatal familiar insomnia and
Gerstmann-Straussler-Scheinker syndrome in humans [3,4]. Clinically
these diseases are characterised by dementia and motor dysfunction,
while neuropathologically by amyloid deposition (in the form of prion
protein), spongiform changes in the brain and neuronal loss [5]. The
conformational changes of the normal form of the protein (PrPC) to the
disease-related scrapie isoform (PrPSc) are considered to be responsible
for these diseases [6]. More and more experimental evidence supports
that metal ions, especially copper(II) may take part in the biochemical
processes related to the normal function of prion protein and/or its
conformational changes. As a consequence, the interaction between
copper(II) ion and prion protein and its peptide fragments was widely
studied. Several reports can be found about the binding affinity of metal
ions to prion protein. The high copper(II) binding affinity is due to the
imidazole side chains of histidine residues in the sequence, which are
primary binding sites for metal ions. It is widely accepted that at least
six histidyl residues of human prion protein can take part in copper
binding. These include four histidines of the octarepeat (His61, His69,
His77 and His85) and two histidines (His96 and His111) outside the
octarepeat domain. It is suggested by G. Legname et al. that all copper-
binding sites are important to preserve the functional conformation of
PrPC. The ability of PrPC in binding copper is key for maintaining the
protein function and preventing its conversion to the prion state. In-
deed, minimal structural changes especially at a non-octarepaet copper-
binding site, may be sufficient to alter PrPC conformation and function,
which may modulate its propensity to prion conversion [7,8].
The octarepeat was first described as the primary copper(II) binding
site of the natural protein, but our systematic studies on the peptide
fragments of the protein revealed that the order of copper(II) binding
affinity of the various histidyl sites is His111>His96>His(octar-
epeat) [9–12]. The enhanced thermodynamic stability of the copper(II)
complexes with the fragments containing His111 or His96 residues can
be easily explained by the difference in chelate ring sizes formed with
histidines inside and outside the octarepeat domain. Histidines of the
octarepeat fragments are preceded by proline which is break-point for
amide deprotonation [13], and as a consequence amide coordination
can only occur towards the C-terminus in the form of a seven-mem-
bered chelate [14–16]. The thermodynamic stability of the peptide
complexes having this coordination mode is smaller than those formed
with His96 and/or His111 in the form of six-membered chelates
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[10–12,17]. The size of chelate rings and the coordinated donor atoms
are the same for His96 and His111, but the stability constants are al-
ways higher for the copper(II)-peptide complexes containing His111
residues. However, this trend is just the opposite for the nickel(II)
complexes [18]. Our studies also revealed that the sequence -GTHS-,
which contains short side chains around His96, is better suited for the
strict square planar coordination geometry of nickel(II) complexes apart
from the position of this binding site in the studied peptides chain. On
the other hand, the formation of 5-coordinated copper(II) species is
usually more favored with the -MKHM- sequence, which contains
longer side chains around His111 and therefore tends to coordinate
axially, however the selectivity depends not only on the neighbouring
amino acids but the distant amino acids also have an influencing role.
These observations were reported by the studies of octapeptides con-
taining both the MKHM and GTHS sites [19]. These studies are now
completed by an N- and C-terminally protected tridecapeptide
(Ac-PHAAAGTHSMKHM-NH2), which also contains the main binding
site of the octarepeat domain in addition to the above mentioned His96
and His111 moieties. The glycine amino acids of the octarepeat part are
replaced by alanine because of the CD studies. Shorter fragments of the
tridecapeptide (Ac-PHAAAGTHS-NH2 and Ac-PHAAA-NH2) were also
studied to clarify the differences in the metal-binding ability of histidine
residues at different positions in the prion protein.
In addition to the complex formation, copper ions play an important
role in various oxidative reactions of peptides. It has an importance also
in the case of prion protein. Copper-bound prion protein undergoes
redox cycling in the presence of electron donors, such as superoxide
ions, dopamine or ascorbate. The mechanism of oxidative damage to
proteins involves catalysis by transition metals [20,21]. This process
consists of reduction of Fe(III) or Cu(II) by electron donors, such as
O2−, H2O2, ascorbate or thiols, and generation of the hydroxyl radical
through reduction of H2O2 by the reduced metals. This highly reactive
free radical immediately oxidizes neighbouring amino acid residues;
The metal-catalyzed oxidation (MCO) of proteins is mainly a site-spe-
cific process in which only one or a few amino acids at the metal-
binding sites of the protein are preferentially oxidized [22,23]. This
reaction typically results in structural alterations and loss of enzyme
activity [20,21].
Histidine and methionine are the most important targets of protein
oxidation. 2-oxo-histidine was found to be the predominant product of
MCO in histidine containing proteins such as human growth hormone
[24] and human relaxin [25]. Other unidentified protein degradation
products have been detected, including the formation of asparagine
and/or aspartyl from histidyl residues [26,27] Met(O) (methionine
sulfoxide) is proposed to be the major product of MCO of methionine
[28]. Higher oxidized products of methionine may have an additional
oxygen at the sulfur atom or at one of the carbon atoms, or addition of a
perhydroxyl group (OOH) at the sulfur atom [29,30]. The oxidation of
proteins may also lead to cleavage of peptide bonds.
However, in our last publication on this subject the following con-
clusions were drawn. The peptide which does not contain methionine
does not undergo oxidation, only the fragmentation of the peptide chain
is observed. The cleavage of the peptide bonds occurs far away from the
histidine residue. On the other hand, in the case of methionine con-
taining peptides, the peptide chain was not cleaved; the presence of
methionine residues protected the peptides from fragmentation. In
these cases copper(II) ions catalyzed the oxidation of methionine to
methionine sulfoxide. This process occurred randomly, it did not de-
pend on the position of the methionine; methionine residues undergo
oxidation either involved in the coordination of the copper(II) ions, or
near or far the binding sites. Our results revealed that methionine re-
sidues of prion protein can play a role as ROS scavenger [31].
The binding preference of the wild type prion protein is well-known
from earlier studies. However these fragments contain several side
chains which may have an effect on the complex formation processes
even though they are far from the metal binding sites. Therefore in the
continuation of this work we report the interaction of copper(II) and
nickel(II) ions with the Ac-PH85AAAGTH96SM109KH111M112-NH2 in-
cluding both coordination and oxidation. The binding sites are the same
in this peptide, but this contains only amino acids in the direct en-
vironment of the bound metal ion. Although nickel ions have no bio-
logical relevance in the case of prion protein, they are also involved in
this study. The coordination chemistry of copper(II) and nickel(II) ions
are rather similar, therefore nickel(II) ions are commonly used models
of the copper(II) – peptide interactions. However, due to the different
coordination geometry of these metal ions differences may arise; in the
case of the wild type prion protein fragments the metal binding pre-
ference was different; it shows a significant preference for Ni(II)
binding at His96 residue (which is completely opposite to those re-
ported for Cu(II) ion). It can be explained by the effect of the side
chains, while nickel(II) ions form planar species where the shorter side
chains are present, copper(II) ions are stabilized by axial interactions.
Smaller fragments of the tridecapeptide (Ac-PH85AAA-NH2 and Ac-
PH85AAAGTH96S-NH2) were also synthesized and studied for compar-
ison.
2. Experimental
2.1. Chemicals
All solvents and chemicals used for synthesis were purchased from
commercial sources in the highest available purity and used without
further purification.
All N-fluorenylmethoxycarbonyl (Fmoc)-protected amino acids
(Fmoc-Ala-OH, Fmoc-Gly-OH, Fmoc-His(Trt)-OH, Fmoc-Lys(Boc)-OH
(Boc: tert-butyloxycarbonyl), Fmoc-Met-OH, Fmoc-Pro-OH, Fmoc-Ser
(tBu)-OH és Fmoc-Thr(tBu)-OH), 2-(1-H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate (TBTU) and Rink Amide AM
resin was purchased from Novabiochem (Switzerland). N,N-diiso-
propyl-ethylamine (DIEA) and trifluoroacetic acid (TFA) were obtained
from Merck Ltd. N-hydroxybenzotriazole (HOBt), N-methyl-pyrrolidone
(NMP), triisopropylsilane (TIS), 2,2′-(ethylenedioxy)diethanethiol
(DODT), and 2-methyl-2-butanol were Sigma-Aldrich products.
Piperidine, dichloromethane (DCM), diethyl ether (Et2O), acetic acid
(96%) and H2O2 were obtained from Molar Chemicals Ltd., whereas
peptide synthesis grade N,N-dimethylformamide (DMF), acetonitrile
(ACN) and acetic anhydride were from VWR International Ltd. Ethylene
diamine tetraacetic acid disodium salt (Na2EDTA) were from Reanal
Ltd.
The peptides Ac-PHAAAGTHSMKHM-NH2, Ac-PHAAAGTHS-NH2
and Ac-PHAAA-NH2 were synthesized by means of a Liberty 1 solid
phase peptide synthesizer.
Concentrations of the peptide stock solutions were determined by
potentiometric titrations that also supported the purity and the identity
of the substances.
Stock solutions of copper(II) chloride, copper(II) nitrate and nickel
(II) chloride were prepared from analytical grade reagents and their
concentration were measured gravimetrically via the precipitation of
oxinates. The other stock solutions (KOH, HCl, KCl, potassium hydrogen
phthalate) were also prepared from analytical grade reagents.
2.2. Peptide synthesis and purification
The protected peptides were synthesized by means of a microwave-
assisted Liberty Peptide Synthesizer (CEM, Matthews, NC) using the
Fmoc/tBu technique and the TBTU/HOBt/DIPEA (DIPEA: N,N-
Diisopropylethylamine) activation strategy. Removal of the Fmoc pro-
tecting group was carried out at 80 °C with 30W microwave power for
180 s by means of 20% piperidine in DMF. Four times excess of amino
acids and 30W microwave power for 300 s were used for coupling at
80 °C in the presence of 0.5M HOBt and 0.5M TBTU in DMF as an
activator and 2M DIPEA as an activator base. In the case of the peptides
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the free amino terminus was treated with DMF containing 5 V/V% Ac2O
and 6 V/V% DIPEA to obtain the acetylated amino group. The prepared
peptide linked to the resin was washed with dichloromethane, 96%
acetic acid, 2-methyl-2-butanol and diethyl ether. The side chain pro-
tecting groups were cleaved with the mixture of TFA/TIS/H2O/DODT
(94/2.5/2.5/1 V/V%) at room temperature for 2 h. The solution con-
taining the peptide was separated from the resin by filtration, followed
by recovering from the pertinent solution by precipitation with cold
diethyl ether. The precipitate was washed with cold diethyl ether, then
was centrifuged and dried, redissolved in water and finally lyophilized.
The purity of the peptides was checked by analytical RP-HPLC using
a Jasco instrument, equipped with a Jasco MD-2010 plus multi-
wavelength detector. The chromatographic conditions are as follows:
Column: Teknokroma Europa Protein C18 (250× 4.6mm, 300 Å pore
size, 5 μm particle size); elution: gradient elution was carried out using
solvent A (0.1% TFA in water) and solvent B (0.1% TFA in acetonitrile)
at a flow rate of 1mL·min−1, monitoring the absorbance at
222 nm. From 0min to 30min 0% to 20% of ACN
(Ac-PHAAAGTHSMKHM-NH2), from 0min to 30min 0% to 12% of
ACN (Ac-PHAAAGTHS-NH2) A was applied (Scheme 2).
Ac-PHAAAGTHSMKHM-NH2 was purified by the means of pre-
parative HPLC equipped with semipreparative column (Vydac 218TP
C18, 250× 10mm, 300 Å pore size, 5 μm particle size). Gradient elu-
tion was carried out using solvent A (0.1% TFA in water) and solvent B
(0.1% TFA in acetonitrile) at a flow rate of 3mL·min−1, monitoring the
absorbance at 222 nm. From 0min to 30min 95% to 85% then keeping
this ratio for additional 10min.
2.3. Potentiometric measurements
The pH-potentiometric titrations were made in 3.00mL samples at
1–3·10−3M ligand concentration with the metal ion to ligand ratios
between 1:1 to 3:1 for the binary and 1:1:1 to the ternary system. The
titrations were performed with carbonate free stock solution of po-
tassium hydroxide of known concentration. A MOLSPIN pH-meter
equipped with a 6.0234.100 combined glass electrode (Metrohm) was
used for pH measurements (in the pH range 2.5–11.5), while the dosing
of the titrant were made with a MOL-ACS microburette controlled by a
computer.
During the measurements argon was bubbled through the samples
to ensure the absence of oxygen and carbon dioxide. All pH-potentio-
metric measurements were carried out at a constant ionic strength of
0.2M KCl and at a constant temperature (298 K).
The recorded pH readings were converted to hydrogen ion con-
centration as described by Irving et al. [32]. Protonation constants of
the ligands and overall stability (log βpqr) constants of the metal com-
plexes were calculated by means of the general computational pro-
grams (SUPERQUAD [33] and PSEQUAD [34]) based on Eqs. (1) and
(2). + + =p q rM H L M H Lp q r (1)
= [M H L ]
[M] [H] [L]pqr
p q r
p q r (2)
2.4. Spectroscopic measurements
UV–Vis spectra of the complexes were recorded on Hewlett Packard
HP 8453 diode array and Perkin Elmer Lambda 25 double beam spec-
trophotometers. The same concentration range was used as for pH-po-
tentiometry.
Circular dichroism spectra of the complexes were registered on a
JASCO J-810 spectropolarimeter using 1mm and/or cm cells in the
200–800 nm wavelength range at the same concentrations as used in
pH-potentiometry.
2.5. Oxidation of the peptides
The reaction mixture containing 1.1mM of peptides and metal-to-
ligand molar ratio 1:1.1 was incubated at 25 °C for 1 h in the presence of
hydrogen peroxide at metal to H2O2 molar ratio 1:4 for all peptides. The
pH was adjusted to 7.4. The reaction was started by the addition of
hydrogen peroxide, which was freshly prepared. After incubation the
reaction was stopped by addition of Na2EDTA at ligand to Na2EDTA
ratio 1:5. The reaction process was monitored by RP-HPLC at different
time periods. The chromatograms of the reaction mixtures after 1 h 2, 4
and 24 and 96 h indicated no significant difference (the shape, retention
times and intensity of peaks) suggesting the end of reaction after 1 h.
2.6. Isolation of oxidized products
The samples were analyzed by analytical RP-HPLC using a Jasco
instrument, equipped with a Jasco MD-2010 plus multiwavelength
detector. The oxidized products were conducted on a Teknokroma
Europa Protein C18 (250×4.6mm, 300 Å, 5 μm) at a flow rate of
1mL·min−1, monitoring the absorbance at 222 nm. Mobile phases were
water (A) and acetonitrile (B) containing 0.1% TFA. Gradient:
0–3–9–24–30min, 100–100–80–80–100% water containing 0.1% TFA
for PGM; 0–3–9–24–30min, 100–100–88–88–100% water containing
0.1% TFA for PG; 0–3–9–24–30min.
2.7. Mass spectrometry
A maXis II MicroTOF-Q type Qq-TOF MS instrument (Bruker
Daltonik, Bremen, Germany) was used for the MS and MS/MS mea-
surements in positive ion mode. The instrument was equipped with an
electrospray ion source where the spray voltage was 4 kV. N2 was uti-
lized as drying gas. The drying temperature was 200 °C and the flow
rate was 4.0 L/min using the same method described in 2.6. For the MS/
MS experiments, nitrogen was used as the collision gas. The pressure in
the collision cell was determined to be 1.2× 10−2mbar. The precursor
ions for MS/MS were selected with an isolation width of 5m/z units.
The mass spectra were recorded by means of a digitizer at a sampling
rate of 2 GHz. The mass spectra were calibrated externally using the
exact masses of clusters [(Na-formate)n+Na]+ generated from the
electrosprayed solution of sodium formate. The spectra were evaluated
with the DataAnalysis 4.4 software from Bruker. The sample solutions
were introduced either directly into the ESI source with a syringe pump
(Cole-Parmer Ins. Co., Vernon Hills, IL, USA) at a flow rate of 3 μL/min.
3. Results and discussion
3.1. Protonation equilibria of the peptides
The protonation constants of the studied peptides and the stability
constants of the corresponding copper(II) complexes were determined
by means of potentiometric titrations and the data are reported in
Table 1. The tridecapeptide contains a lysine and three histidine re-
sidues (see Scheme 1), while the penta- and nonapeptide contains only
one and two histidine residues respectively. The protonation reactions
of the side-chain imidazole moieties take place in a pH range of 5–8 in
overlapping processes, while the highest pK value of Ac-PHAAAGTH-
SMKHM-NH2 can be unambiguously assigned to the deprotonation of
the ε-ammonium group of the lysyl residue.
3.2. Copper(II) complexes of Ac-PHAAA-NH2
This peptide mimics the complex formation properties of the oc-
tarepeat domain. The histidine residue is the anchor for coordination.
The complex formation begins in the slightly acidic solution by the
coordination of this group, which induces the deprotonation of amide
nitrogens. However, because of the presence of proline, the amide
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deprotonation and coordination occurs towards the C-terminus forming
7-membered chelate ring (Scheme S1). The stability of this coordination
mode is lower than the 6-membered one, and its formation is shifted to
the higher pH values. As a consequence, the hydrolysis and the complex
formation processes are in competition and precipitation occurs around
pH 6. However, when the titration was performed from the basic so-
lution towards the acidic one, the formation of precipitate was avoided.
Stability constants were not determined, but several conclusions can be
drawn from the UV–Vis and CD spectra. The spectra were taken ori-
ginally basic solutions by the addition of acid. There are two well se-
parated absorption maxima in the UV–Vis spectra (Fig. S1); at 520 nm
and 630 nm. The first one is present in the strongly basic solution and
typical for the 4N complexes. Its intensity decreases by decreasing pH
until pH 10, than a red-shift of the absorption maximum occurs till
630 nm, which is characteristic for the 2N species; an amide nitrogen is
coordinated in addition to the imidazole nitrogen. The low intensity
band with an absorption maximum around 650–700 nm relates to the
exclusive coordination of the imidazole nitrogen below pH 6.5. Similar
conclusions can be drawn from the CD spectra (not shown). The N−→
Cu2+ charge transfer band around 305 nm confirms the presence of
amide nitrogens in the coordination sphere of copper(II) ions.
3.3. Copper(II) complexes of Ac-PHAAAGTHS-NH2
The complex formation reaction of this ligand with copper(II) ions
were studied at different metal to ligand ratios. In the case of metal ion
excess precipitation occurred, therefore stability constants were not
determined for dinuclear species. However, this precipitate dissolved
by pH 11, therefore certain consequences can be drawn.
The complex formation begins around pH 4 by the formation of CuL.
A low intensity band can be seen between 650 and 700 nm in the visible
spectra. This can be explained by the formation of macrochelates with
the exclusive coordination of imidazole nitrogens. This is also sup-
ported by the CD spectra because of the lack of any activity in this
wavelength range.
The deprotonation of amide nitrogens occurs at higher pH. Species
with 1, 2 or 3 coordinated amide nitrogens are also present. Due to the
two histidine residues, isomer structures can be formed. If the amide
coordination begins from the histidine at the eight position towards the
N-terminus six-membered chelate forms, while in the other case this
process occurs with histidine at the second position towards the C-
terminus resulting seven-membered chelate.
Table 1
pK values and stability constants of the copper(II) complexes of the studied peptides (I=0.2M KCl, T=298 K, standard deviations are in parentheses).
Ac-PHAAA-NH2 Ac-PHAAAGTHS-NH2 Ac-PHAAAGTHSMKHM-NH2 Ac-(PHGGGWGQ)2-NH2 [14] Ac-GTHSMKHM-NH2 [17]
pK(Im1) 6.43(1) 5.99(1) 5.59(3) 6.77 5.80
pK(Im2) 6.75(1) 6.20(3) 6.97 6.61
pK(Im3) 6.95(3)
pK(Lys) 10.06(6) 10.19
CuH2L 22.10(2)
CuHL 16.89(2) 10.11 15.72
CuL 5.54(5) 9.88(8) 5.39 9.16
CuH−1L −1.03(9) 2.60(6) – 2.67
CuH−2L −7.63(6) −5.10(5) −7.68 −5.50
CuH−3L −15.18(6) −15.26(5) −17.44 −15.78
CuH−4L −28.45
Cu2H–1L 7.13(8)
Cu2H–2L 1.26(2) 0.18
Cu2H–3L −6.03(4) −6.32
Cu2H–4L −13.68(3) −17.49 −14.00
Cu2H–5L −22.14(3) −26.55 −22.86
Cu2H–6L −31.17(2) −35.94 −33.43
Cu2H–7L −46.42
Cu2H–8L −57.72
Cu3H–3L −1.89(12)
Cu3H–4L −8.45(13)
Cu3H–5L −15.27(9)
Cu3H–6L −23.23(13)
Cu3H–7L −31.70(10)
Cu3H–8L −42.59(28)
Cu3H–9L −52.96(10)
Scheme 1. Structure of the studied Ac-PHAAAGTHSMKHM-NH2 peptide
Scheme 2. Peptide fragmentation notation using the scheme of Roepstorff and
Fohlman [35]
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It is proved by the comparison of the CD spectra of the His85 and
His96 model peptides (Fig. 1), that the first equivalent of copper(II)
coordinates to the binding site outside the octarepeat domain. How-
ever, the one magnitude order higher stability constant proposes the
axial coordination of the other histidine side chain. On the other hand,
above 8.5 this peptide is able the bind two equivalent of copper(II) ions.
It is also proved by the CD spectra (Fig. 2). The CD activity is increasing
until this pH; there is a positive and a negative Cotton effect around 500
and 600 nm, respectively. If the pH is further increased the intensity of
the CD band is decreasing drastically around 500 nm, which will be
turned to negative Cotton effect by pH 11. The negative Cotton effect
can be seen also at this pH around 600 nm in the envelope curve, but
disappears at higher pH. It turned out by the comparison of the CD
spectra that below pH 11, one copper(II) ion is bounded to the PHAAA-,
and the other one is bounded to the -GTHS domain forming (7,5,5) and
(6,5,5) chelates, respectively with the same (N(Im),N−,N−,N−) donor
atoms. Above pH 11 the CD spectrum is in good agreement with the
spectra of common tetrapeptide complexes. According to this it is
suggested, that the histidine residue of the octarepeat part is displaced
by a fourth amide nitrogen and a (5,5,5)-membered fused chelate
forms.
3.4. Copper(II) complexes of Ac-PHAAAGTHSMKHM-NH2
The Ac-PHAAAGTHSMKHM-NH2 tridecapeptide contains three
histidine residues mimicking three metal binding sites from three dif-
ferent regions of the prion protein. As it was expected this ligand can
bind three equivalents of Cu(II) ions, the stability constants of the
peptides are summarized in Table 1, whereas the corresponding spe-
ciation curves are shown on Fig. 3 and S2. There is a low intensity
absorption band in the pH range 4–6, and its maximum is around
650–700 nm, which refers to the exclusive coordination of the imida-
zole nitrogens. It is also supported by the lack of CD activity in this pH
range. In addition to the lysine side chain, one of the imidazole nitro-
gens is also protonated in the CuH2L species, and the other two imi-
dazole nitrogens are coordinated to the copper(II) ion. The formation of
the singly protonated CuHL species is almost parallel with CuH2L. Its
logK(Cu(II)+NIm) value is 6.83, which is between the value of com-
plexes with the coordination of two and three imidazole nitrogens. This
data proves the presence of macrochelates in which two or three imi-
dazole nitrogens are coordinated in this pH range. The further increase
of the pH values results in a continuous blue shift of the absorption
spectra and the appearance of the N−→Cu2+ CT band
(λmax= 310 nm) in the CD spectra. These processes are due to the
deprotonation of the amide nitrogens and the formation of the 2 N CuL,
3 N CuH−1L and 4 N CuH−2L species. The latter species has high sta-
bility and dominant in the pH range 8–10. There is no other change in
the spectra above pH 10, since the last deprotonation process is owing
to the deprotonation of the ε-ammonium group of lysine side chain.
The amount of dinuclear complexes is considerable even in equi-
molar solution. The statistical probability of the formation of dinuclear
species in the case of three binding sites and one metal ion is 44% [11].
The amount of dinuclear species is slightly lower than the statistical
value; 30% in the physiological pH-range, that leads us to conclude that
the three binding sites are not equivalent. However, this value reaches
the statistical data above pH 10.
The intensities of the CD spectra (Fig. 4) are rather low, and in the
case of 1:1 and 2:1 copper(II) to ligand ratios, their exteriors are similar
Fig. 1. CD spectra of the Cu(II): Ac-PHAAAGTHS-NH2 system at 1:1 (a) and 2:1
(b) metal to ligand ratio, the Cu(II):Ac-PHAAA-NH2 (c) and Cu(II):Ac-GTHS-
NH2 systems at 1:1 ratio (d) at pH 11, and the sum of the CD spectra of the Cu
(II):Ac-PHAAA-NH2= 1:1 and the Cu(II):Ac-GTHS-NH2= 1:1 systems (e).
Fig. 2. CD spectra of the Cu(II):Ac-PHAAAGTHS-NH2 system at 2:1 metal to
ligand ratio at different pH values (cL= 3·10−3M).
Fig. 3. Metal ion speciation of the copper(II)-Ac-PHAAAGTHSMKHM-NH2
system in equimolar solution (cCu(II) = cL= 1mM).
Fig. 4. CD spectra of the Cu(II):Ac-PHAAAGTHSMKHM-NH2 system at 1:1 (a),
2:1 (b) and 3:1 (c) metal to ligand ratio and CD spectrum of the Cu
(II):Ac-GTHSMKHM-NH2 at 1:1 metal to ligand ratio (d) around pH 8.
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to the Cu2H–6L species of Ac-GTHSMKHM-NH2 which also can be cal-
culated by a simple superposition of the spectra of CuH−3L of the His96
and His111 model peptides. It means that the first two equivalents of
copper(II) ion coordinate to the sequence mimicking histidines outside
the octarepeat domain (-GTHS- and -MKHM-) in comparable con-
centration. However, in the case of 3:1 copper(II) to ligand ratio the
increase of the negative Cotton effect below 500 nm refers to the co-
ordination of the imidazole nitrogen of the octarepeat part of the
peptide. It means that the metal binding affinity of histidine mimicking
the octarepeat domain is decreased, preference for the binding sites
follows the order His111~His96>His85.
3.5. Nickel(II) complexes of Ac-PHAAAGTHSMKHM-NH2
The complex formation processes of this ligand was also studied by
nickel(II) ions. The stability constants of the formed nickel(II) com-
plexes and these data of the peptides used for comparison are collected
in Table 2. It was found that this peptide is not able to bind as many
nickel(II) ions as the number of independent histidyl residues in the
sequence; only mono and dinuclear species are present in the solution.
The species NiHL predominates at 1:1 and 2:1 metal to ligand ratios
between pH 6 and 8. The lack of CD activity suggests octahedral geo-
metry, where macrochelate forms by the coordination of imidazole
nitrogens. Its relatively high stability (logK(Ni(II)+NIm)= 4.13) sup-
ports the coordination of more than two imidazole nitrogens. This value
was 3.52 in the case of Ac-GTHSMKHM-NH2, where the coordination of
two imidazole nitrogens is possible. There is an extra base consuming
process above pH 8, which is accompanied by the appearance of the
intensive square planar band in the UV–Vis spectra. The stoichiometry
of the first amide coordinated complex is NiL, in which the lysine side
chain is protonated, therefore its exact formula is (NiH−1L)H. The de-
protonation of the amide nitrogens is not fully cooperative because of
the presence and the coordination of the three imidazole nitrogens. The
stoichiometry of the main species formed in the pH range 8.8–10.0 is
NiH−2L ((NiH−3L)H), where the absorption maxima do not change,
only the intensity is increasing. (5,5,6)-membered chelate rings are
formed, with (3N−,NIm) coordination modes. The formation of
[NiH−3L] species is not accompanied by any spectral change, since it is
due to the deprotonation of the ε-amino group of the lysine residue. In
addition to the above-mentioned species, dinuclear complexes are also
formed even in the equimolar samples. The ratio of this species is ap-
proximately 20%. On the other hand they are the exclusive species at
2:1 nickel to ligand ratio in the pH range where the deprotonation of
amide nitrogens occurs. There is possibility for the formation of co-
ordination isomers due to the presence of the three histidine residues.
Information about the ratio of these isomers can be obtained from the
CD spectra. Fig. S3 presents the effect of increasing concentration of
nickel ions on the CD spectra at pH 10.5. The shape and the intensity of
the spectrum at 1:1 ratio is similar to the Ni(II)-Ac-GTHS-NH2 system.
This points to the fact that the first equivalent nickel ion binds to the
-GTHS- part of the peptide which represents the His96 domain of the
human prion protein. The intensity is decreasing by the increasing
amount of nickel ion, which can be explained by the coordination of
nickel ion to the -MKHM- part with reversed CD activity.
3.6. Copper(II)-nickel(II) mixed metal complexes of Ac-
PHAAAGTHSMKHM-NH2
Since the peptide is able to bind three equivalents of Cu(II) ions or
two equivalents of Ni(II) ions, the Cu(II):Ni(II):L= 1:1:1 system was
also studied. Due to the formation of precipitate around pH 8, stability
constants were not determined. However, it dissolved by increasing pH,
therefore spectroscopic measurements were carried out. Fig. 5 shows
the change of CD spectra of the equimolar Cu(II):L= 1:1 system at
pH 10.5 by the addition of nickel(II) ions. In the initial solution copper
(II) ions are coordinated in comparable concentration to the sequences
mimicking histidines from outside the octarepeat domain (-GTHS- and
-MKHM-). Continuously increasing CD activity can be seen by the ad-
dition of nickel ions. The nickel ions are not able to remove copper(II)
ions, only redistribute between the available binding sites; copper(II)
will bind mainly to -MKHM-, while nickel(II) will bind to the -GTHS-
sequence. The distribution of the metal ions can be seen on Fig. 6.
3.7. Copper(II) catalyzed oxidation of Ac-PHAAAGTHS-NH2
Ac-PHAAAGTHS-NH2 peptide was oxidized with the Cu
(II):L:H2O2=1:1:4 system around pH 7.4 where the 3 N and 4 N species
are present in approximately 1:1 ratio.
An oxidized product containing an additional oxygen atom and
peptide fragments are also formed during the oxidation. Scheme 2
presents the peptide fragmentation notation for a tetrapetide. Peptide
fragment ions are indicated by a, b, or c if the charge is retained on the
N-terminus and by x, y or z if the charge is maintained on the C-ter-
minus. The subscript indicates the number of amino acid residues in the
fragment [35].
Three main products are identified in the HPLC chromatogram; the
ligand with an additional oxygen atom (y9+O) and two fragments of
it; the N-terminal fragment containing six amino acid residues (c6) and
the oxidized form of the C-terminal fragment (z3+O).
The MS/MS spectrum of the oxidized product of
Ac-PHAAAGTHS-NH2 ([y9+O]2+ ion) is shown on Fig. 7. It is frag-
mented into c6+ and [z3+O]+ ions. The identity of these ions was
proved also by fragmentation, which is presented on Figs. 8 and 9.
During the fragmentation of the ion c6+ the first step is the formation of
b6+ by the loss of NH3. Then not only the series of b+ ions, but also
a2+-a5+ ions were identified. The fragmentation of b6+ and a5+ ion
begins on the C-terminus, and the amino acids are removed step by
step.
Table 2
Stability constants of the nickel(II) complexes of Ac-PHAAAGTHSMKHM-NH2
(I= 0.2M KCl, T= 298 K, standard deviations are in parentheses).
Ac-PHAAAGTHSMKHM-NH2 Ac-GTHSMKHM–
NH2 [19]
Ac-
GTHS-
NH2
[36]
Ac-
MKHM-
NH2
[36]
NiHL 14.19(2) 13.71 13.09
NiL 5.83(8) 2.82 5.08
NiH−2L −11.12(5) −10.92
NiH−3L −20.95(6) −20.62
Ni2H–2L −7.31(5) −7.99
Ni2H–4L −24.48(5)
Ni2H–5L −33.36(4) −33.22
Ni2H–6L −43.73(6) −43.59
Fig. 5. Effect of the addition of Ni(II) ions on the CD spectra of the Cu
(II):Ac-PHAAAGTHSMKHM-NH2= 1:1 system around pH 10.5.
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The fragmentation pattern of [z3+O+2H]+ ion is used for
finding the localization of oxidation. The first step is the loss of a H2O
molecule and the formation of an ion with 324.130m/z, then an ion
with 324.130m/z is formed by the loss of an NH3 molecule. However,
the oxidation of histidine is proved by the loss of CH3NO (45.011m/z).
The presence of the internal [TH+O]+ ion also supports the formation
of 2-oxo-histidine. This ion loses a CO molecule, then the cleavage of
the oxidized imidazole ring occurs by the loss of C2H2N2O group
(60.016m/z).
Fig. 6. Coordination isomers of the 4N coordinated species formed in the Cu(II):Ac-PHAAAGTHSMKHM-NH2= 1:1 system and the supposed structure of the mixed
metal complex formed in the Ni(II):Cu(II):Ac-PHAAAGTHSMKHM-NH2= 1:1:1 system.
Fig. 7. MS/MS spectrum of the [y9+O]2+ ion formed during the oxidation of
Ac-PHAAAGTHS-NH2.
Fig. 8. MS/MS spectrum of the [c6]+ ion formed during the oxidation of
Ac-PHAAAGTHS-NH2.
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3.8. Copper(II) catalyzed oxidation of Ac-PHAAAGTHSMKHM-NH2
The Ac-PHAAAGTHSMKHM-NH2 peptide was oxidized by the Cu
(II):L:H2O2=1:1:4 system. The oxidation of this peptide is excessively
complicated. There are five amino acids namely three histidine and two
methionine residues which are involved in the oxidation, and the ad-
dition of two oxygen atoms on the same side chain is also possible. The
formation of fragments containing 1–5 additional oxygen atoms and the
fragmentation of the Gly(6)-Thr(7) peptide bonds also occurs in this
system. However, the chance for the multiple oxidation of peptides is
very low in biological systems, therefore we will focus on the discussion
of the singly oxidized products.
The most intensive peaks in the MS/MS spectra of [y10+O]+
(Fig. 10) arise from the fragmentation of the b6+ ion with 547.262m/z
(calculated value 547.262), according to it, the oxidation of the
His2(His85) residue does not occur in this case. However, the oxidation
of His8 (His96) is proved by the internal [His8(O)S-H2O]+ species with
223.080m/z (calculated value 223.083), while there is no direct proof
for the oxidation of His12(His111), it may also occur, but in smaller
extent. On the other hand, on the base of the highly oxidized products
the oxidation of every histidine residue may occur, even the addition of
two oxygen atoms on the same site is also possible. There are several
proofs for the doubly oxidation of histidine residues. For example in the
fragment [c9+ 3O]+ three additional oxygen atoms are bound, al-
though it contains only two histidine residues. Hence, one of these
histidine residues is doubly oxidized. Therewith the loss of a CH3NO
group supports the oxidation of a histidine residue, while the loss of a
CHNO2 group supports the doubly oxidation of it.
Fig. 9. MS/MS spectrum of the [z3+O+2H]+ ion formed during the oxidation of Ac-PHAAAGTHS-NH2.
Fig. 10. MS/MS spectrum of the singly oxidized product of Ac-PHAAAGTHSMKHM-NH2.
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The order of tendency for oxidation is His96>His85≫His111.
However in the case of the singly oxidized products, only the oxidation
of His96 residue is proved. The difference in the copper(II) ion oxida-
tion susceptibility may be due to the steric arrangement of the peptide.
The copper(II) ion is easily available for the hydrogen peroxide in the
case of the -GTHS- domain, where the side chains are relatively small.
However, owing to the axial interactions of the larger side chains in the
-MKHM- domain the copper(II) ion is locked and therefore the oxida-
tion at that position occurs to a smaller extent.
The oxidation of the two methionine residues cannot be avoided.
For example the [y1+O]+ ion with 165.068m/z (calculated value
165.069) supports the oxidation of Met13 (Met112), while in the case of
the fragmentation of the quadruply oxidized peptide the [y2+O-
CH3SOH]+ ion with 238.127m/z (calculated value 238.130) supports
the oxidation of Met10 (Met109), and the presence of TH(O)SM(O) with
617.266m/z (calculated value 617.271) confirms the oxidation of both
His8 (His85) and Met10 (Met109) residues.
4. Conclusions
Previous studies on the copper(II) and nickel(II) complexes of pep-
tide fragments of prion protein indicated a different binding preference
for the metal ion coordination at the various histidyl sites. In the case of
the histidine residues outside the octarepeat region His96>His111
was reported for nickel(II) and the opposite trend for copper(II), while
the histidine residue in the octarepeat region has smaller metal binding
ability with both metal ions. However, in the case of
Ac-GTHSMKHM-NH2 the binding sites which are outside the octarepeat
region are equivalent for copper(II), while His96 is preferred for nickel
(II). The same consequence can be drawn in the case of the presently
studied Ac-PHAAAGTHSMKHM-NH2 tridecapeptide. The tridecapep-
tide is able to bind three equivalent of copper(II) ions, since the histi-
dine residues behave as independent metal binding sites. Nevertheless
the metal binding ability of histidine residue mimicking the octarepeat
domain (His85) is decreased, while the other parts of the peptide mi-
micking the histidine residues outside the octarepeat domain binds the
copper(II) ions in comparable concentration. On the other hand, this
peptide is able to coordinate only two equivalents of nickel ion on the
domains outside the octarepeat region, furthermore the His96 binding
site is more effective for the nickel ions. It is also supported by the
formation of mixed metal complexes, where the nickel(II) ions bind the
-GTHS- domain, the copper(II) ions are displaced from there and occupy
the -MKHM- domain. The lower metal binding ability of the histidine in
the octarepeat region is confirmed by the shorter fragments. The metal
binding of the His85 residue in the case of these fragments is accom-
panied by precipitation.
The order of copper(II) binding affinity of the various histidyl sites
is His111~His96>His85, while the order of oxidation activity is
His96>His85≫His111. The metal binding ability of the histidine
residues outside the octarepeat region is almost comparable, but the
susceptibility for oxidation differs. The first order can be explained by
the fact that the coordination mode at the -GTHS- and -MKHM- domain
is the same, (Nim,N−,N−) in the form of (6,5,5)-membered fused che-
late rings, which is preferred over the (7,5,5)-membered one.
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